Moleculin Biotech
MBRX
MBRX
9 hedge funds and large institutions have $254K invested in Moleculin Biotech in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VKH
1
Virtu KCG Holdings
New York
|
$66K |
| 2 |
AIM
2
Acrospire Investment Management
Chicago,
Illinois
|
$9K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$14K |
| 4 |
WA
4
WFG Advisors
Dallas,
Texas
|
$2K |
Top Sellers
| 1 |
SIM
1
Spark Investment Management
New York
|
$0 |
| 2 |
2
Barclays
London,
United Kingdom
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$4K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$5K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
IG
1
ING Group
Amsterdam,
Netherlands
| $122K | 20,000 | – | – |
|
|
VKH
2
Virtu KCG Holdings
New York
| $66K | 11,614 | +11,614 | New |
|
3
Citigroup
New York
| $29K | 5,000 | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | 2,495 | +1,404 | +129% |
|
|
AIM
5
Acrospire Investment Management
Chicago,
Illinois
| $9K | 1,600 | +1,600 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $5K | 917 | -432 | -32% |
|
|
7
Morgan Stanley
New York
| $4K | 700 | -500 | -42% |
|
|
NFG
8
Next Financial Group
Houston,
Texas
| $3K | 500 | – | – |
|
|
WA
9
WFG Advisors
Dallas,
Texas
| $2K | 400 | +400 | New |
|
|
SIM
10
Spark Investment Management
New York
| – | – | -18,800 | Closed |
|
|
11
Barclays
London,
United Kingdom
| – | – | -1,348 | Closed |
|